Stroke is one of the leading causes of death and disability around the world. Large vessel occlusion (LVO), causes high rates of death and disability without treatment. A quick diagnosis and treatment is crucial for the best outcomes. Traditionally, LVO has been diagnosed through imaging techniques such as CT scans or MRIs.
In a new study, two biomarkers obtained with a blood test (GFAP and D-Dimer), combined with the field assessment stroke triage for emergency destination (FAST-ED) investigators were able to identify LVOs less than 6 hours from the onset of symptoms.
The use of these biomarkers could help prehospital stroke patients get on the right path for the right intervention even more quickly than today. Early intervention is key to preventing brain cell loss from a stroke.
Click here to read the full article.
Comments